Log on / register
Feedback | Support | My details
Xenoantigen, an alphaGal epitope-expression construct driven by the hTERT-promoter, specifically kills human pancreatic cancer cell line.
Sawada T, Yamada O, Yoshimura N, Hatori K, Fuchinoue S, Teraoka S
Cancer Cell Int 2002 Oct 3, 2:14
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.


Research article    
Designing a HER2/neu promoter to drive 1,3galactosyltransferase expression for targeted anti-Gal antibody-mediated tumor cell killing
Lanteri M, Ollier L, Giordanengo V, Lefebvre JC
Breast Cancer Research 2005, 7:R487-R494 (3 May 2005)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.